Lisa Marshall
Â鶹Ãâ·Ñ°æÏÂÔØBoulder was the first site to roll out a federally-funded study led by the COVID-19 Prevention Network at the Fred Hutchinson Cancer Research Center in Seattle. Study leaders vaccinated 11 of the roughly 700 Â鶹Ãâ·Ñ°æÏÂÔØBoulder student volunteers who will ultimately participate.
For nearly one year, a group of scientists and volunteers from across the university has met seven days a week, often sleeping just a few hours a night, to bring students back to campus safely.
New research finds that only one in five college students who tested positive for COVID-19 while living in residence halls infected their roommates.
A nation-wide effort first launched in New Hampshire in 2009 is enlisting gun retailers in the fight against suicide. Researchers at Â鶹Ãâ·Ñ°æÏÂÔØBoulder want to learn how it's working and what can be done to make it work even better.
In the years after female faculty members have children, their productivity––in terms of papers published––drops 20 percent. Male faculty see no such decline. Researchers say different roles in parenting are likely to blame and the gap could have long-term impacts on higher education.
As supply increases, so do questions about how the COVID-19 vaccines work and what they do and don’t do. We caught up with Professor Matt McQueen, director of epidemiology, for answers.
Facial recognition technology is now embedded in everything from our phones and computers to surveillance systems at the mall and airport. But it tends to misidentify certain populations and can be used to discriminate. Microsoft Research Fellow Morgan Klaus Scheuerman wants to change that.
New research suggests drugs called PARP inhibitors, designed to treat breast and ovarian cancers, work differently than previously presumed. It also shines a light on how they do work, opening the door for improved next-generation drugs.
A new Â鶹Ãâ·Ñ°æÏÂÔØBoulder study shows that a key protein involved in learning and memory formation functions differently in males than in females.
As leaders face tough decisions about who to vaccinate against COVID-19, a new study finds that vaccinating adults 60 or older first will save the most lives in the long term.